ACHILLES THERAPEUTICS PL-ADR (ACHL) Forecast, Price Target & Analyst Ratings

NASDAQ:ACHL • US00449L1026

Current stock price

1.48 USD
+0.01 (+0.68%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ACHILLES THERAPEUTICS PL-ADR (ACHL).

Forecast Snapshot

Consensus Price Target

Price Target
$6.12
+ 313.51% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Apr 2, 2025
Period
Q4 / 2024
EPS Estimate
-$0.37
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
40.00%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$6.12
Upside
+ 313.51%
From current price of $1.48 to mean target of $6.12, Based on 6 analyst forecasts
Low
$6.06
Median
$6.12
High
$6.30

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

6 Wall Street analysts provided a forecast for the next 12 months for ACHL. The average price target is 6.12 USD. This implies a price increase of 313.51% is expected in the next year compared to the current price of 1.48.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

ACHL Current Analyst RatingACHL Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5

Analyst Ratings History

ACHL Historical Analyst RatingsACHL Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
40.00%
ACHL was analyzed by 6 analysts. The buy percentage consensus is at 40. So analysts seem to be rather negative about ACHL.
In the previous month the buy percentage consensus was at a similar level.
ACHL was analyzed by 6 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2024-04-05Chardan CapitalMaintains Buy -> Buy
2024-04-05Piper SandlerDowngrade Overweight -> Neutral
2023-12-14B of A SecuritiesDowngrade Buy -> Underperform
2023-08-07Chardan CapitalReiterate Buy -> Buy
2023-05-11Chardan CapitalMaintains Buy -> Buy
2022-12-07Chardan CapitalMaintains Buy
2022-12-07Piper SandlerMaintains Overweight
2021-04-26Chardan CapitalInitiate Buy
2021-04-26OppenheimerInitiate Outperform
2021-04-26JP MorganInitiate Underweight
2021-04-26B of A SecuritiesInitiate Buy
2021-04-26Piper SandlerInitiate Overweight

Next Earnings Forecast Details

Next Earnings Details

Release Date
Apr 2, 2025
Period
Q4 / 2024
EPS Estimate
-$0.37
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
20.17%
Number of Analysts
3

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
5.26%

Next Earnings Summary

ACHL is expected to report earnings on 4/2/2025. The consensus EPS estimate for the next earnings is -0.37 USD and the consensus revenue estimate is 0 USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2024 - 2031

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
ACHL revenue by date.ACHL revenue by date.
N/AN/AN/AN/AN/AN/AN/AN/A
EBITDA
YoY % growth
ACHL ebitda by date.ACHL ebitda by date.
-6.73M-13.48M
-100.30%		-32.96M
-144.51%		-60.91M
-84.80%		-74.19M
-21.80%		-70.542M
4.92%		N/A
-2.21%		N/A
-38.96%		N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
ACHL ebit by date.ACHL ebit by date.
-6.9M-13.78M
-99.71%		-33.73M
-144.78%		-64.2M
-90.34%		-77.88M
-21.31%		-75.255M
3.37%		N/A
-2.83%		N/A
-36.98%		N/A
49.73%		N/A
-20.00%		N/A
-20.00%		N/A
-143.22%		N/A
-7.65%		N/A
22.34%
Operating Margin
ACHL operating margin by date.ACHL operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
ACHL eps by date.ACHL eps by date.
N/AN/AN/A-9.62-1.82
81.08%		-1.74
4.40%		N/A
89.45%		N/A
33.33%		N/A
-2,183.33%		N/A
47.81%		N/A
-17.48%		N/AN/AN/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth		-0.37
20.17%		-0.32
-5.40%		-0.24
40.29%		-0.17
63.88%		-0.16
55.56%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		-24.072M
-62.64%		N/AN/AN/AN/A
EBIT
Q2Q % growth		-24.072M
-23.36%		-13.77M
3.70%		-10.71M
39.83%		-7.65M
62.53%		-7.14M
70.34%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

ACHL Yearly Revenue VS EstimatesACHL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2031 20M 40M 60M 80M
ACHL Yearly EPS VS EstimatesACHL Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 -2 -4 -6 -8

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
-17.11%
EPS Next 5 Year
0.30%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

ACHILLES THERAPEUTICS PL-ADR / ACHL Forecast FAQ

Can you provide the average price target for ACHILLES THERAPEUTICS PL-ADR stock?

6 analysts have analysed ACHL and the average price target is 6.12 USD. This implies a price increase of 313.51% is expected in the next year compared to the current price of 1.48.

When does ACHILLES THERAPEUTICS PL-ADR (ACHL) report earnings?

ACHILLES THERAPEUTICS PL-ADR (ACHL) will report earnings on 2025-04-02, after the market close.

What are the consensus estimates for ACHILLES THERAPEUTICS PL-ADR (ACHL) next earnings?

The consensus EPS estimate for the next earnings of ACHILLES THERAPEUTICS PL-ADR (ACHL) is -0.37 USD and the consensus revenue estimate is 0 USD.